Prestige Consumer Healthcare Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Prestige Consumer Healthcare Inc. on October 31, 2019. The filing serves to announce financial results for the fiscal quarter and six months ended September 30, 2019, and to disclose investor presentations made on that date.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are incorporated by reference but not detailed in the body of this 8-K.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text. It directs readers to the attached exhibits for the specific results of operations and financial condition for the periods ended September 30, 2019.
Guidance, Outlook, and Management Commentary
Management began making presentations to investors on October 31, 2019, utilizing slides attached as Exhibit 99.2. The Company expects to use this Investor Presentation, potentially with modifications, for investor and analyst presentations during the fiscal year ended March 31, 2020. The filing includes a standard disclaimer that the Company undertakes no duty to update or revise the information contained in the presentation.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and earnings per share figures for the quarter and six months ended September 30, 2019.
- Examine Exhibit 99.2 (Investor Presentation) for management's outlook, strategic initiatives, and any forward-looking guidance for the fiscal year ending March 31, 2020.
- Verify the specific details of the "Results of Operations" referenced in Item 2.02 by cross-referencing the attached exhibits.
- Confirm that the information in the Investor Presentation is considered "furnished" and not "filed" under Section 18 of the Exchange Act, limiting liability for forward-looking statements.